Donor safety confirmed
- PMID: 39136968
- PMCID: PMC11372387
- DOI: 10.1182/bloodadvances.2024013477
Donor safety confirmed
Conflict of interest statement
Comment on
-
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim.Blood Adv. 2024 Aug 13;8(15):4196-4206. doi: 10.1182/bloodadvances.2024012646. Blood Adv. 2024. PMID: 38687368 Free PMC article.
Similar articles
-
[Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].Beitr Infusionsther Transfusionsmed. 1996;33:81-92. Beitr Infusionsther Transfusionsmed. 1996. PMID: 8974711 German.
-
Review of blood donor deferral with emphasis on donor and patient safety.Transfus Clin Biol. 2023 Feb;30(1):56-62. doi: 10.1016/j.tracli.2022.07.002. Epub 2022 Jul 11. Transfus Clin Biol. 2023. PMID: 35835317
-
Pandemic blood donor demographics - Do changes impact blood safety?Transfusion. 2021 May;61(5):1389-1393. doi: 10.1111/trf.16320. Epub 2021 Feb 20. Transfusion. 2021. PMID: 33554333 Free PMC article.
-
Donor Screening and Deferral.Clin Lab Med. 2021 Dec;41(4):563-577. doi: 10.1016/j.cll.2021.07.001. Clin Lab Med. 2021. PMID: 34689965 Review.
-
Moving on from voluntary non-remunerated donors: who is the best blood donor?Br J Haematol. 2011 Sep;154(6):763-9. doi: 10.1111/j.1365-2141.2011.08708.x. Epub 2011 May 3. Br J Haematol. 2011. PMID: 21539535 Review.
References
-
- Stefanski HE, Kuxhausen M, Bo-Subait S, et al. Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim. Blood Adv. 2024;8(15):4196–4206. - PubMed
-
- Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988;72(6):2074–2081. - PubMed
-
- Bennett CL, Evens AM, Andritsos LA, et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the research on adverse drug events and reports (RADAR) project. Br J Haematol. 2006;135(5):642–650. - PubMed
-
- Vasiliu IM, Petri MA, Baer AN. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol. 2006;33(9):1878–1880. - PubMed
-
- Nagler A, Korenstein-Ilan A, Amiel A, Avivi L. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol. 2004;32(1):122–130. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical